Inventor · disambiguated record
Christopher L. Parks
Also filed as: PARKS CHRISTOPHER · PARKS CHRISTOPHER L · PARKS CHRISTOPHER LEE
23 granted patents·10 pending applications·108 citations·filing 2001–2025
93Inventor score
Files withINT AIDS VACCINE INITIATIVE16INT AIDS VACCINE INITIATIVE INC6WYETH CORP4PARKS CHRISTOPHER L3CLARKE DAVID KIRKWOOD2
Top patents by PatentIndex Score
33 records- 0195US6664066B2Modified Morbillivirus V proteinsWYETH CORP·Filed 2001·Granted Dec 16, 2003·71 cites·34 claims
- 0285US9347065B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2013·Granted May 24, 2016·7 cites·4 claims
- 0384US6673572B2Methods for rescue of RNA virusesWYETH CORP·Filed 2002·Granted Jan 6, 2004·20 cites·81 claims
- 0482US12305190B2Vesicular stomatitis virus and virus rescue systemINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted May 20, 2025·0 cites·18 claims
- 0577US8287878B2Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereofCLARKE DAVID KIRKWOOD·Filed 2005·Granted Oct 16, 2012·5 cites·17 claims
- 0676US8647638B2Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereofCLARKE DAVID KIRKWOOD·Filed 2012·Granted Feb 11, 2014·5 cites·8 claims
- 0775US2024374710A1Vaccine Compositions For Preventing Coronavirus DiseaseINT AIDS VACCINE INITIATIVE INC·Filed 2023·Application pending·0 cites
- 0874US10844095B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Nov 24, 2020·0 cites·7 claims
- 0973US11891416B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE INC·Filed 2020·Granted Feb 6, 2024·0 cites·9 claims
- 1072US11667930B2Vesicular stomatitis virus and virus rescue systemINT AIDS VACCINE INITIATIVE INC·Filed 2019·Granted Jun 6, 2023·0 cites·8 claims
- 1165US10792357B2Optimized HIV envelope gene and expression thereofINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Oct 6, 2020·0 cites·9 claims
- 1264US12311021B2Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteinsINT AIDS VACCINE INITIATIVE INC·Filed 2021·Granted May 27, 2025·0 cites·20 claims
- 1363US10894080B2Transgenic VERO-CD4/CCR5 cell lineINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Jan 19, 2021·0 cites·8 claims
- 1463US10544430B2Vesicular stomatitis virus and virus rescue systemINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Jan 28, 2020·0 cites·18 claims
- 1563US10202424B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Feb 12, 2019·0 cites·11 claims
- 1663US9802986B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 31, 2017·0 cites·8 claims
- 1761US10279027B2Transgenic Vero-CD4/CCR5 cell lineINT AIDS VACCINE INITIATIVE·Filed 2017·Granted May 7, 2019·0 cites·11 claims
- 1859US2010215691A1Recombinant viral vectorsPARKS CHRISTOPHER L·Filed 2010·Application pending·0 cites
- 1958US9402894B2Viral particles derived from an enveloped virusINT AIDS VACCINE INITIATIVE·Filed 2012·Granted Aug 2, 2016·0 cites·7 claims
- 2058US2013095556A1Novel vesicular stomatitis virus and virus rescue systemINT AIDS VACCINE INITIATIVE·Filed 2012·Application pending·0 cites
- 2154US9925258B2Replication-competent VSV-HIV Env vaccinesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Mar 27, 2018·0 cites·10 claims
- 2253US9944935B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Apr 17, 2018·0 cites·11 claims
- 2351US2006153870A1Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNAPARKS CHRISTOPHER L·Filed 2005·Application pending·0 cites
- 2450US9610346B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Apr 4, 2017·0 cites·7 claims
- 2548US10220087B2Optimized HIV envelope gene and expression thereofINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Mar 5, 2019·0 cites·10 claims
- 2646US2009175900A1Methods for packaging propagation-defective vesicular stomatitis virus vectorsWYETH CORP·Filed 2008·Application pending·0 cites
- 2746US2025302896A1Vesicular stomatitis virus marburg virus vaccineINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 2845US10081796B2Neutralization-resistant CDV mutants and viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Sep 25, 2018·0 cites·9 claims
- 2945US2009162321A1Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g proteinWYETH CORP·Filed 2008·Application pending·0 cites
- 3044US2002055173A1Method for preparing adenovirus vectors, vectors so prepared, and uses thereofFiled 2001·Application pending·0 cites
- 3143US9562078B2Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutationsINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Feb 7, 2017·0 cites·8 claims
- 3241US2013189754A1Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodiesPARKS CHRISTOPHER L·Filed 2012·Application pending·0 cites
- 3339US2005089985A1Rescue of canine distemper virus from cdnaAMERICAN CYANAMID CO·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher L. Parks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →